Inventor · disambiguated record
Mathew G. Miller
Also filed as: MILLER MATHEW G
15 granted patents·11 pending applications·25 citations·filing 2013–2025
90Inventor score
Top patents by PatentIndex Score
26 records- 0198US11278600B2Human alpha-galactosidase variantsCODEXIS INC·Filed 2020·Granted Mar 22, 2022·4 cites·20 claims
- 0298US10973888B2Human alpha-galactosidase variantsCODEXIS INC·Filed 2020·Granted Apr 13, 2021·5 cites·13 claims
- 0395US11497798B2Human alpha-galactosidase variantsCODEXIS INC·Filed 2020·Granted Nov 15, 2022·3 cites·10 claims
- 0495US11236311B2T7 RNA polymerase variantsCODEXIS INC·Filed 2020·Granted Feb 1, 2022·3 cites·25 claims
- 0591US10738286B2T7 RNA polymerase variantsCODEXIS INC·Filed 2018·Granted Aug 11, 2020·3 cites·22 claims
- 0689US12257291B2Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2024·Granted Mar 25, 2025·0 cites·19 claims
- 0789US12018295B2Engineered DNA polymerase variantsCODEXIS INC·Filed 2021·Granted Jun 25, 2024·1 cites·14 claims
- 0889US10793841B2T7 RNA polymerase variantsCODEXIS INC·Filed 2018·Granted Oct 6, 2020·4 cites·26 claims
- 0988US2025027061A1T7 rna polymerase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 1086US11236312B2T7 RNA polymerase variantsCODEXIS INC·Filed 2020·Granted Feb 1, 2022·1 cites·10 claims
- 1185US2024263154A1Engineered dna polymerase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 1283US11060075B2Engineered DNA polymerase variantsCODEXIS INC·Filed 2019·Granted Jul 13, 2021·1 cites·27 claims
- 1381US12129494B2T7 RNA polymerase variantsCODEXIS INC·Filed 2021·Granted Oct 29, 2024·0 cites·17 claims
- 1478US2025027062A1Engineered dna polymerase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 1575US12263207B2Human alpha-galactosidase variantsCROSSWALK THERAPEUTICS INC·Filed 2021·Granted Apr 1, 2025·0 cites·33 claims
- 1675US12129495B2Engineered DNA polymerase variantsCODEXIS INC·Filed 2022·Granted Oct 29, 2024·0 cites·35 claims
- 1775US2025250552A1Engineered dna polymerase variantsCODEXIS INC·Filed 2025·Application pending·0 cites
- 1868US2024376448A1Engineered rna polymerase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 1968US2025163401A1Engineered rna ligasesCODEXIS INC·Filed 2024·Application pending·0 cites
- 2066US2024376447A1Engineered rna polymerase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 2166US2024309353A1Engineered dna ligase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 2262US2023183790A1Recombinant reverse transcriptase variantsCODEXIS INC·Filed 2022·Application pending·0 cites
- 2358US12344872B2Engineered ligase variantsCODEXIS INC·Filed 2018·Granted Jul 1, 2025·0 cites·1 claims
- 2458US2017360900A1Human alpha-galactosidase variantsCODEXIS INC·Filed 2015·Application pending·0 cites
- 2551US9611515B2Pentose fermentation by a recombinant microorganismCODEXIS INC·Filed 2013·Granted Apr 4, 2017·0 cites·11 claims
- 2650US2025223582A1Engineered rna ligasesCODEXIS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mathew G. Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →